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Table 1. Summary of studies of HIV and obstetric complications which included births by vaginal delivery.
































































Retrospective Cohort One maternity hospital
in Paris, France (2001
–2006)
All HIV+ women with an
undetectable viral load
at 36 weeks gestation
and one HIV2 control









c-section and for HIV+
















Prospective Cohort One maternity hospital
in Nairobi, Kenya
(1986–1989)
All HIV+ women and
HIV2 women who
















Prospective Cohort One maternity hospital
in Addis Ababa, Ethiopia
(1993–1995)
All HIV+ women and
HIV2 women matched
to the HIV+ women


























































































































et al., 2001 [53]
Retrospective
Cohort





























1.2 (82) 0.7 (1,540) 1.89
(0.24–14.94)
-




One high risk obstetric
unit in Bloemfontein,
South Africa (2001)
All HIV+ women and































tology in Mexico City,
Mexico (1989–1997)
44 HIV+ women and
two HIV2 controls for
each HIV+ woman,


















centres in Columbia and
North Carolina, USA
(2000–2007)
All HIV+ women on ART
and two HIV2 controls
for each HIV+ woman
matched for age, race,
parity, care location,
delivery mode,





















































































































20% of all community
hospitals in the USA
(1994 & 2003)
All HIV+ and HIV2
pregnant women bet-
ween 15-44 years













Prospective Cohort One tertiary hospital in
Kigali, Rwanda
(1992–1993)
All HIV+ women and
one HIV2 control for
each HIV+ woman
matched for age. Only
included women
resident in Kigali who
attended antenatal
clinic two days a week
and wished to deliver in
the hospital.




















HIV+: 58.7% had a
c-section HIV2:




















Retrospective Cohort One tertiary hospital in
Detroit, USA
(2000–2005)
All HIV+ women and a
random selection of
HIV2 women.
HIV+: 39.9% had a
c-section HIV2:










Prospective Cohort Four prenatal clinics in
New York, USA (1985–
1989)
All HIV+ women who
had a live, singleton
birth; in three of the
prenatal clinics all
HIV2 women were
also recruited, and in
one of the clinics two
HIV2 controls were
selected for each HIV+
woman.
HIV+: 12.0% had a
c-section HIV2:





























































































































Prospective Cohort One university hospital
in Kampala, Uganda
(1988–1990)
All HIV+ women and a
random 10% sample of
HIV2 women. Only
included women who
lived within 15km of
Mulago and agreed to
deliver in the hospital.
No difference in the

















Prospective Cohort One maternity hospital
in Belo Horizonte,
Brazil (2001–2003)
82 HIV+ women and
123 HIV2 women
matched on mode of
delivery, gestational
age at delivery and
maternal age. Only
included women if they




HIV+: 72.0% had a
c-section HIV2:













the birth canal or
curettage
2.4 (82) 0 (123) 7.67 (0.36–
161.86)
-
Van Eijk et al.,
2007 [33]





hospital if they had an
uncomplicated singleton
pregnancy at more than
32 weeks gestation,
resided in Kisumu and
had no underlying
chronic illnesses.












































































































































One tertiary hospital in
Gautang, South Africa
(2003)





risk or high risk
pregnancy) and one
HIV2 control selected
























All HIV+ treated with
ART and two HIV2




singleton or twin. The
controls had to be
healthy and not
referred, not have had
obstetric complications
in the past and live
near the hospital.
HIV+: 40.8% had a
c-section HIV2:









for the Studies of
Hypertension in
Pregnancy









All HIV+ women and
HIV2 women matched
to the HIV+ women for
age and parity.





as an increment in
systolic blood pressure
of 30 mmHg and in
diastolic blood
pressure of 15 mmHg
from the pre- or early
pregnancy level of
blood pressure















































































































All HIV+ women and










$140 mm Hg or a
diastolic blood
pressure of $ 90
mmHg, on at least
2 occasions 4 hours
or more apart and
proteinuria of $
0.3 g/24 hours)





which could not be
explained by other
cerebral conditions,
in a patient with
pre-eclampsia










44 HIV+ women and





HIV+: 29.9% had a
c-section HIV2:





















at a gestational age of
















































































































































All HIV+ women on ART
and two HIV2 controls
for each HIV+ woman
matched for age, race,
parity, care location,
delivery mode,




HIV+: 51.0% had a
c-section HIV2:
























20% of all community
hospitals in the USA
(1994 & 2003)
All HIV+ and HIV2
pregnant women


















One hospital in Vellore,
India (2000–2002)
All HIV+ and HIV2
women.
HIV+: 58.7% had a
c-section HIV2:
















































































































































Prospective Cohort One university hospital
in Kampala, Uganda
(1988–1990)
All HIV+ women and a
random 10% sample of
HIV2 women. Only
included women who
lived within 15km of
Mulago and agreed to
deliver in the hospital.
No difference













Prospective Cohort One tertiary hospital
in Benin City, Nigeria
(2007–2008)
HIV+ women who did




duration of ART intake
of less than 8 weeks. A
single HIV2 control was















Retrospective Cohort All main obstetric
facilities, a social
security hospital and
two private clinics in La
Romana, Dominican
Republic (2003–2006)














Prospective Cohort One hospital in Imphal,
India (2006–2008)
50 HIV+ and 100 HIV2
















Prospective Cohort One referral centre in
Barcelona, Spain
(2001–2003)
All HIV+ and HIV2
women delivering after





defined as the new
onset of hypertension
with 2 readings $6






plus a dipstick reading
of at least 1+ for
proteinuria (0.1 g/l)














































































































Prospective Cohort One maternity hospital
in Kenya, Nairobi (Study
dates not provided)






Not clear Pre-eclampsia (no
further details
provided)




et al., 2002 [17]
Prospective Cohort Two hospitals in
London, UK (1990–2001)
214 HIV+ women and a
single HIV2 control for
each HIV+ woman







to Higgins and de
Swiet [74]





et al., 2001 [53]
Retrospective
Cohort

































One tertiary hospital in
Kigali, Rwanda
(1992–1993)
All HIV+ women and
one HIV2 control for
each HIV+ woman
matched for age. Only
included women
resident in Kigali who
attended antenatal
clinic two days a week





















One hospital in Vellore,
India (2000–2002)




















































































































Four prenatal clinics in
New York, USA (1985–
1989)
All HIV+ women who
had a live, singleton
birth; in three of the
prenatal clinics all HIV2
women were also
recruited, and in one of
the clinics two HIV2
controls were selected













Case-control One hospital in Mulago,
Uganada (2001–2002)
Case of ruptured uterus
and controls were
selected from women
who had a gestation of
24 or more weeks,
delivered a live, singleton
baby by vaginal delivery,
did not have episiotomy,


























enrolled and one HIV2
woman enrolled for









Chamiso, 1996 [36] Prospective
Cohort
One maternity hospital
in Addis Ababa, Ethiopia
(1993–1995)
All HIV+ women and
HIV2 women matched
























































































































































44 HIV+ women and two


























matched the first HIV2
woman delivering after
the infected index case
on age ethnicity, parity
and whether admitted to













20% of all community
hospitals in the USA
(1994 & 2003)
All HIV+ and HIV2
pregnant women
between 15–44 years





















One hospital in Kigali,
Rwanda (1988–1989)
All HIV+ women and an
equal number of HIV2
women matched for
age and parity. Women
had to have lived for at
least six months in a
district within a diameter














Four prenatal clinics in
New York, USA (1985–
1989)
All HIV+ women who
had a live, singleton
birth; in three of the
prenatal clinics all HIV2
women were also
recruited, and in one of
the clinics two HIV2
controls were selected
for each HIV+ woman.
HIV+: 12.0% had a
c-section HIV2:














































































































Case-control One hospital in
Kampala, Uganda
(1996–1997)















24 hours apart, with




delivery and 42 days
postpartum










All HIV+ women and for
every HIV+ woman the
next two HIV2 women
who delivered were
selected as controls.
HIV+: 8.1% had a c-
section HIV2:
11.0% had a c-
section
Yes Puerperal sepsis (no
further details)








in Belo Horizonte, Brazil
(2001–2003)
82 HIV+ women and
123 HIV2 women
matched for mode of
delivery, gestational
age at delivery and
maternal
age. Only included




HIV+: 72.0% had a
c-section HIV2:












et al., 1994 [35]
Prospective
Cohort
One health centre in
Nairobi, Kenya
(1989–1991)
All HIV+ women and a
sample of HIV2
women matched for
age and parity to each
HIV+ woman.









of .38oC, foul lochia
and uterine
tenderness
10.3 (253) 4.2 (265) 2.64 (1.28–
5.47)
-
1Information was not supplied in the published paper so whether antiretroviral treatment should have been available was based on the study dates and study location; for two studies it was not clear from the study dates and
location whether ART would be available so the information was inferred from the literature.
a) Bangkok, Thailand between 2001: No ART treatment based on the UNAIDS data accessed on 29th October 2012 at http://www.unaids.org/en/dataanalysis/datatools/aidsinfo/.
b) Bloemfontein, South Africa in 2001: No ART treatment based on the UNAIDS data accessed on 29th October 2012 at http://www.unaids.org/en/regionscountries/countries/southafrica/.
2Adjusted for smoking and cocaine use.









































































Table 2. Summary of studies of HIV and obstetric complications which only looked at births by caesarean section.
Reference Study design Study Setting Study Population ART Available
Definition of obstetric
complication























All HIV+ women and an
equivalent number of
HIV2 women who




any bleeding during surgery
requiring blood transfusion
or a fall in packed cell
volume $4%
23.1 (52) 40.4 (52) 0.44
(0.19–1.04)
-
Hypertensive diseases of pregnancy
Chama and Morrupa,
2008 [44]




All HIV+ women and an
equivalent number of
HIV2 women who











Retrospective Cohort Two health
centres (one of














above 38uC with uterine
tenderness and requiring
antibiotics treatment in
the absence of other
aetiology for fever









All HIV+ women and an
equivalent number of
HIV2 women who
delivered by elective c-
section.
Yes Wound sepsis (not clearly
defined)
3.8 (52) 5.8 (52) 0.65
(0.10–4.08)
-









matched with the first
HIV2 woman delivering
by elective c-section
after the infected index





Yes Wound infection (no
further details)
















































































Reference Study design Study Setting Study Population ART Available
Definition of obstetric
complication























were matched to an




Yes Endometritis (no further
details)
4.8 (62) 0 (62) 7.35 (0.37–
145.40)
-





All women of known
HIV status having a c-
section at a gestational
age of .20 weeks and
who delivered a
singleton infant of at
least 500g birth weight.
Yes Maternal sepsis defined as



















tenderness in the absence
of a non-uterine source









All HIV+ women on ART
and having a c-section;
for every HIV+ woman
the HIV2 women who
delivered by c-section
before and after were
selected as controls.
Yes Wound infection or
hematoma (no further
details)




using clinical signs and a
positive vaginal swab




et al., 1999 [15]






were matched to HIV2
women for indication
for c-section, stage of
labour, number of
foetuses and date of
delivery.
No Sepsis (no further
details)











































































Reference Study design Study Setting Study Population ART Available
Definition of obstetric
complication























2.2 (45) 4.4 (90) 0.49
(0.05–4.50)
-
Moodlier et al., 2007
[49]






a c-section with known
HIV status.
No1 Wound sepsis defined as
the breakdown of the
suture line as a result of a
subcutaneous infectious
process
5.4 (186) 8.0 (175) 0.65
(0.28–1.51)
-
Endometritis defined as a
sustained pyrexia (auxiliary
temp greater than 38uC)
post-delivery (excluding
the first 24 hours)










Do not provide specific
details on how HIV+ and
HIV2 women were
selected but did exclude
women who had a preterm
delivery.
Yes Endometritis (no further
details)












were matched to an
HIV2 woman on age,
race, year of delivery
and indication for c-
section.














interval, exclusive of the
first 24 hours after delivery,
with uterine tenderness,
foul lochia, and no other
apparent causes for fever











































































Reference Study design Study Setting Study Population ART Available
Definition of obstetric
complication
















































of HIV status, and
subsequently HIV status
was ascertained. Women
were excluded if they
had diabetes mellitus.
No Wound infection (no
further details)




fever of $38oC on 2
occasions at least 4 hours
apart and more than 24
hours post-operatively,
tachycardia of .100 beats
per minute on 2 occasions
at least 4 hours apart and
more than 24 hours post-
operatively, and
tenderness of the cervix
on movement











a c-section with known
HIV status.
No Wound infection was
diagnosed in the presence
of purulent discharge










































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Reference Study design Study Setting Study Population ART Available
Definition of obstetric
complication

















$38oC on 2 successive
readings at an 8 hour
interval (excluding the 24
hours after delivery) and
uterine tenderness, slight
vaginal bleeding or foul
smelling odour and no
other apparent causes of
fever
25.6 (164) 20.9 (382) 1.30 (0.85–1.99)-
1Information was not supplied in the published paper so whether antiretroviral treatment should have been available was based on the study dates and study location; for one study it was not clear from the study dates and
location whether ART would be available so the information was inferred from the literature.
a) Durban, South Africa in 2004: No ART treatment based on the UNAIDS data accessed on 20th December 2012 at http://www.unaids.org/en/regionscountries/countries/southafrica/.














































































complication Completeness of data
Adjustment for
confounders Selection of comparison group
HAEMORRHAGE
Aboud et al. 2009 [56] with
supplementary information
from [75]
No definitions provided for
antepartum haemorrhage or
postpartum haemorrhage
The pregnancy was followed
prospectively, although it
was not clear who collected
the outcome data
6.9% of HIV+ women were
lost to follow up compared
with 7.6% of HIV2 women
None Unclear on exact selection methods; however no HIV2
women were selected from one of the study sites
High risk Unclear risk Low risk High risk High risk
Azria et al., 2010 [16] Definition provided for
postpartum haemorrhage
Hospital record review Eight medical records of
HIV+ women were missing
data; no information for
HIV2 women
HIV+ and HIV2 women were
matched on key confounders
HIV+ and HIV2 women selected from the same hospital
Low risk High risk Unclear risk Low risk Low risk
Braddick et al., 1990 [32] Definition provided for
antepartum haemorrhage
Hospital record review 0.6% of women refused to
participate
None HIV2 Women were selected based on close proximity to
the follow up clinic, but this selection criteria was not
applied to HIV+ women
Low risk High risk Low risk High risk High risk
Chamiso, 1996 [36] No definitions provided for
placenta praevia, postpartum
haemorrhage or retained placenta
Recorded by a general
practitioner blinded to
woman’s HIV status
22% of HIV+ women were
lost to follow up
HIV+ and HIV2 women were
matched on key confounders
HIV+ and HIV2 women selected from the same hospital
High risk Low risk High risk Low risk Low risk
Chanrachakul et al., 2001 [53] No definitions provided for
postpartum haemorrhage or
retained placenta
Hospital record review No information provided None HIV+ and HIV2 women were enrolled from the same
hospital; however HIV+ women were managed using
traditional labour management and HIV2 women were
managed using active labour management
High risk High risk Unclear risk High risk High risk
De Groot et al., 2003 [46] Definitions provided for
antepartum haemorrhage and
postpartum haemorrhage
Hospital record review 2% of medical files
selected into study were
missing HIV status
None HIV+ and HIV2 women selected from the same hospital
Low risk High risk Low risk High risk Low risk
Figueroa-Damian, 1999 [28] No definition provided for
postpartum haemorrhage
The pregnancy was followed
prospectively, although it was
not clear who collected the
outcome data
No information provided HIV+ and HIV2 women were
matched on key confounders
HIV+ and HIV2 women selected from the same hospital
High risk Unclear risk Unclear risk Low risk Low risk
Haeri et al., 2009 [21] No definition provided for
placental abruption
Hospital record review No information provided HIV+ and HIV2 women were
matched on key confounders
HIV+ and HIV2 women selected from the same two
tertiary care centres
High risk High risk Unclear risk Low risk Low risk
Kourtis et al., 2006 [22] ICD-9 codes were used to
define antepartum
haemorrhage
Hospital discharge data No information provided None1 HIV+ and HIV2 women selected from the same hospitals













































































complication Completeness of data
Adjustment for
confounders Selection of comparison group
Leroy et al., 1998 [37] No definitions provided for
postpartum haemorrhage or
retained placenta
Recorded by a midwife
blinded to woman’s HIV status
5.2% refusal rate; 4.7% lost to
follow up
HIV+ and HIV2 women were
matched on key confounders
HIV+ and HIV2 women selected from the same hospital
High risk Low risk Low risk Low risk Low risk
Lionel et al., 2008 [51] Placental abruption defined as
grade III but no definitions for
placenta praevia and PPH
Hospital record review No information provided None HIV+ and HIV2 women selected from the same hospital
Unclear risk High risk Unclear risk High risk Low risk
Louis et al., 2006 [23] No definition provided for
postpartum haemorrhage
Hospital record review No information provided None HIV+ and HIV2 women selected from the same hospital
High risk High risk Unclear risk High risk Low risk





Method of ascertaining outcome
not clear
10% of HIV+ women
refused to participate
None HIV+ and HIV2 women selected from the same clinics
High risk Unclear risk Low risk High risk Low risk
Mmiro et al., 1993 [39] No definitions provided for
antepartum haemorrhage or
postpartum haemorrhage
Hospital record review No information provided None HIV+ and HIV2 women selected from the same hospital
High risk High risk Unclear risk High risk Low risk
Peret et al., 1993 [30] Definition provided for
postpartum haemorrhage
The pregnancy was followed
prospectively, although it was
not clear who collected the
outcome data
No information provided HIV+ and HIV2 women were
matched on key confounders
HIV+ and HIV2 women selected from the same hospital
Low risk Unclear risk Unclear risk Low risk Low risk




1.5% of women had missing
data and were excluded
None HIV+ and HIV2 women selected from the same hospital
High risk Unclear risk Low risk High risk Low risk
HYPERTENSIVE DISEASES OF PREGNANCY
Aboud et al. 2009 [56] with
supplementary information
from [75]
No definition provided for
hypertension
The pregnancy was followed
prospectively, although it
was not clear who collected
the outcome data
6.9% of HIV+ women were
lost to follow up compared
with 7.6% of HIV2 women
None Unclear on exact selection methods; however no HIV2
women were selected from one of the study sites
High risk Unclear risk Low risk High risk High risk
Bodkin et al., 2005 [47] No definitions provided for
pregnancy-induced
hypertension or eclampsia
Hospital record review 49.6% of women refused
to be tested for HIV
HIV+ and HIV2 women were
only matched on whether
their pregnancy was high-risk,
medium-risk or low-risk
HIV+ and HIV2 women selected from the same hospital
High risk High risk High risk High risk Low risk




No information provided HIV+ and HIV2 women were
matched on key confounders














































































complication Completeness of data
Adjustment for
confounders Selection of comparison group
Low risk Unclear risk Unclear risk Low risk Low risk
Chamiso, 1996 [36] Definition provided from
pregnancy-induced
hypertension
Recorded by a general
practitioner blinded to
woman’s HIV status
22% of HIV+ women were
lost to follow up
HIV+ and HIV2 women were
matched on key confounders
HIV+ and HIV2 women selected from the same hospital
Low risk Low risk High risk Low risk Low risk
De Groot et al., 2003 [46] Definitions provided for pre-
eclampsia and eclampsia
Hospital record review 2% of medical files selected
into study were missing HIV
status
None HIV+ and HIV2 women selected from the same hospital
Low risk High risk Low risk High risk Low risk
Figueroa-Damian, 1999 [28] No definition provided for
acute hypertensive disorder of
pregnancy
The pregnancy was followed
prospectively, although it was
not clear who collected the
outcome data
No information provided HIV+ and HIV2 women were
matched on key confounders
HIV+ and HIV2 women selected from the same hospital
High risk Unclear risk Unclear risk Low risk Low risk
Frank et al., 2004[48] Definitions provided for
pregnancy-induced
hypertension and pre-
eclampsia but not for
eclampsia
Hospital record review 27% of files reviewed did
not have known HIV status
None HIV+ and HIV2 women selected from the same hospital
and clinics
Unclear risk High risk High risk High risk Low risk
Haeri et al., 2009 [21] Definition provided for pre-
eclampsia but not for
gestational hypertension
Hospital record review No information provided HIV+ and HIV2 women were
matched on key confounders
and adjusted analysis
conducted
HIV+ and HIV2 women selected from the same two
tertiary care centres
Unclear risk High risk Unclear risk Low risk Low risk




Hospital discharge data No information provided None1 HIV+ and HIV2 women selected from the same hospitals
Low risk High risk Unclear risk High risk Low risk
Lionel et al., 2008 [51] No definitions provided for
pre-eclampsia and eclampsia
Hospital record review No information provided None HIV+ and HIV2 women selected from the same hospital
High risk High risk Unclear risk High risk Low risk
Mattar et al., 2004 [31] Definition provided for pre-
eclampsia
Hospital record review No information provided None HIV+ and HIV2 women selected from the same clinic
Low risk High risk Unclear risk High risk Low risk
Mmiro et al., 1993 [39] Definition provided for
hypertension
Hospital record review No information provided None HIV+ and HIV2 women selected from the same hospital













































































complication Completeness of data
Adjustment for
confounders Selection of comparison group





No information provided State that HIV2 women were
matched to HIV+ women but
do not state what the
matching characteristics were
HIV+ and HIV2 women selected from the same hospital
High risk Unclear risk Unclear risk Unclear risk Low risk
Roman-Poueriet et al., 2009
[29]
No definition provided for
pregnancy-induced
hypertension
Hospital record review No information provided None Women were recruited from a range of public, private
clinics and hospitals and a specialist HIV clinic
High risk High risk Unclear risk High risk Unclear risk
Singh et al., 2009 [52] No definition provided for
pre-eclamptic toxaemia
States that the ‘‘antenatal
complications in both study
groups were observed’’
No information provided None HIV+ and HIV2 women selected from the same hospital
High risk Unclear risk Unclear risk High risk Low risk
Suy et al., 2006 [13] Definition provided for pre-
eclampsia
Using a database No information provided Adjusted analysis was
conducted but it is not clear
what factors were adjusted for,
therefore only the crude
estimate was extracted
HIV+ and HIV2 women selected from the same hospital
Low risk High risk Unclear risk High risk Low risk




No information provided None HIV+ and HIV2 women selected from the same hospital
High risk Unclear risk Unclear risk High risk Low risk
Wimalasundera et al., 2002
[17]




No information provided HIV+ and HIV2 women were
matched on key confounders
HIV+ and HIV2 women selected from the same hospitals
Low risk Unclear risk Unclear risk Low risk Low risk
DYSTOCIA




Hospital record review No information provided None Although HIV+ and HIV2 women were enrolled from the
same hospital, HIV+ women were managed using
traditional labour management and HIV2 women were
managed using active labour management
Low risk High risk Unclear risk High risk High risk
Leroy et al., 1998 [37] No definitions provided for
dystocia or abnormal
presentation
Recorded by a midwife
blinded to woman’s HIV status
5.2% refusal rate; 4.7% lost
to follow up
HIV+ and HIV2 women were
matched on key confounders
HIV+ and HIV2 women selected from the same hospital
High risk Low risk Low risk Low risk Low risk
Lionel et al., 2008 [51] No definition provided for
uterine rupture
Hospital record review No information provided None HIV+ and HIV2 women selected from the same hospital
High risk High risk Unclear risk High risk Low risk




10% of HIV+ women
refused to participate
None HIV+ and HIV2 women selected from the same clinics













































































complication Completeness of data
Adjustment for
confounders Selection of comparison group
Wandabwa et al., 2008 [40] Definition provided for uterine
rupture




No information provided Adjusted analysis conducted HIV+ and HIV2 women selected from the same hospital
Low risk Low risk Unclear risk Low risk Low risk
INTRAUTERINE INFECTION
Aboud et al. 2009 [56] with
supplementary information
from [75]
No definition provided for
puerperal sepsis
The pregnancy was followed
prospectively, although it was
not clear who collected the
outcome data
6.9% of HIV+ women were
lost to follow up compared
with 7.6% of HIV2 women
None Unclear on exact selection methods; however no HIV2
women were selected from one of the study sites
High risk Unclear risk Low risk High risk High risk
Chamiso, 1996 [36] No definition provided for
endometritis
Recorded by a general
practitioner blinded to
woman’s HIV status
22% of HIV+ women were
lost to follow up
HIV+ and HIV2 women were
matched on key confounders
HIV+ and HIV2 women selected from the same hospital
High risk Low risk High risk Low risk Low risk
Chanrachakul et al., 2001 [53] No definition provided for
puerperal infection
Hospital record review No information provided None Although HIV+ and HIV2 women were enrolled from the
same hospital, HIV+ women were managed using
traditional labour management and HIV2 women were
managed using active labour management
High risk High risk Unclear risk High risk High risk
Figueroa-Damian, 1999 [28] No definition provided for
endometritis
The pregnancy was followed
prospectively, although it was
not clear how the outcome
data was collected
No information provided HIV+ and HIV2 women were
matched on key confounders
HIV+ and HIV2 women selected from the same hospital
High risk Unclear risk Unclear risk Low risk Low risk
Fiore et al., 2004 [55] No definition provided for
endometritis
Women were evaluated for
the development of obstetric
complications
No information provided HIV+ and HIV2 women were
matched on key confounders
HIV+ and HIV2 women selected from the same
delivering centres
High risk Low risk Unclear risk Low risk Low risk
Kourtis et al., 2006 [22] ICD-9 codes used to define
major puerperal sepsis
Hospital discharge data No information provided None1 HIV+ and HIV2 women selected from the same hospitals
Low risk High risk Unclear risk High risk Low risk
Lepage et al. 1991 [38] No definition provided for
endometritis
Hospital record review 21% refusal rate; 16% of
HIV2 women and 21% of
HIV+ women were lost to
follow up
HIV+ and HIV2 women were
matched on key confounders
HIV+ and HIV2 women selected from the same hospital
High risk High risk High risk Low risk Low risk




10% of HIV+ women
refused to participate
None HIV+ and HIV2 women selected from the same clinics
High risk Unclear risk Low risk High risk Low risk
Okong et al. 2004 [41] Definition provided for
endometritis
Cases of endometritis were
identified by midwives
8% of cases and controls
refused to participate













































































complication Completeness of data
Adjustment for
confounders Selection of comparison group
Low risk Low risk Low risk High risk Low risk
Onah et al., 2007 [43] No definition provided for
puerperal sepsis
Hospital record review 19% of HIV2 women had to
be excluded because their
medical records could not
be located
None HIV+ and HIV2 women selected from the same hospital
High risk High risk Low risk High risk Low risk
Peret et al., 1993 [30] Definition provided for
endometritis
The pregnancy was followed
prospectively, although it was
not clear who collected the
outcome data
No information provided HIV+ and HIV2 women were
matched on key confounders
HIV+ and HIV2 women selected from the same hospital
Low risk Unclear risk Unclear risk Low risk Low risk
Temmerman et al., 1994 [35] Definition provided for
endometritis
Identified by a research nurse 2.3% women refused to
participate; missing data for
38% of HIV+ and 35% of HIV2
women on endometritis
HIV+ and HIV2 women were
matched on key confounders
HIV+ and HIV2 women selected from the same health
centre
Low risk Low risk High risk Low risk Low risk




















































































No information provided No information provided None HIV+ and HIV2 women selected from the same hospital
Low risk Unclear risk Unclear risk High risk Low risk
HYPERTENSIVE DISEASES OF PREGNANCY
Chama and Morrupa,
2008 [44]
No definition provided for
pregnancy-induced hypertension
No information provided No information provided None HIV+ and HIV2 women selected from the same hospital
High risk Unclear risk Unclear risk High risk Low risk
INTRAUTERINE INFECTION
Cavasin et al., 2009 [25] Definition provided for
endometritis, but not for septic
pelvic thrombosis
Hospital record review No information provided None HIV+ and HIV2 women selected from the same two health
centres
Unclear risk High risk Unclear risk High risk Low risk
Chama and Morrupa,
2008 [44]
No definition provided for wound
sepsis
No information provided No information provided None HIV+ and HIV2 women selected from the same hospital
High risk Unclear risk Unclear risk High risk Low risk
Fiore et al., 2004 [55] No definitions provided for wound
infection or endometritis
Women were evaluated for
the development of obstetric
complications
No information provided HIV+ and HIV2 women were
matched on key confounders
HIV+ and HIV2 women selected from the same delivering
centres
High risk Low risk Unclear risk Low risk Low risk
Grubert et al., 1999
[18]




No information provided HIV+ and HIV2 women were
matched on key confounders
HIV+ and HIV2 women selected from the same medical
facility
High risk Unclear risk Unclear risk Low risk Low risk
Louis et al., 2007 [26] Definitions provided maternal




No information provided Adjusted analysis conducted HIV+ and HIV2 women selected from the same medical
centres
Low risk Unclear risk Unclear risk Low risk Low risk
Maiques et al., 2010
[14]
Definition provided for




No information provided None HIV+ and HIV2 women selected from the same hospital
Unclear risk Unclear risk Unclear risk High risk Low risk
Maiques-Montesinos
et al., 1999 [15]
No definitions provided for sepsis,
wound infection/haematoma or
endometritis
Hospital record review No information provided HIV+ and HIV2 women were
matched on key confounders
HIV+ and HIV2 women selected from the same hospital
High risk High risk Unclear risk Low risk Low risk
Moodlier et al., 2007
[49]
Definitions provided wound sepsis
and endometritis
Hospital record review Only 1% of charts were
missing, but state that about
half of the women refused
HIV testing
None HIV+ and HIV2 women selected from the same hospital













































































complication Completeness of data Adjustment for confounders Selection of comparison group
Panburana et al., 2003
[54]
No definition provided for
endometritis
Simply states that all
complications were ‘‘recorded
in both study and control
groups’’
No information provided None HIV+ and HIV2 women selected from the same hospital
High risk Unclear risk Unclear risk High risk Low risk
Rodriguez et al., 2001
[27]
Definition provided for endometritis
and wound infection, but not for
sepsis
Hospital record review 11% of HIV+ women did not
have records available for
review
HIV+ and HIV2 women were
matched on key confounders
HIV+ and HIV2 women selected from the same hospital
Unclear risk High risk Low risk Low risk Low risk
Semprini et al., 1995
[20]
No definitions provided for sepsis,




No information provided HIV+ and HIV2 women were
matched on key confounders
HIV+ and HIV2 women selected from the same centres
High risk Unclear risk Unclear risk Low risk Low risk
Urbani et al., 2001 [50] Definition provided for endometritis
but not for wound infection
Identified by a researcher 95% of women undergoing
c-section were recruited
None HIV+ and HIV2 women selected from the same hospitals
Unclear risk Low risk Low risk High risk Low risk
Zvandasara et al., 2007
[45]
Definition provided for wound
sepsis
Identified by a researcher No patients were excluded None HIV+ and HIV2 women selected from the same hospital
Low risk Low risk Low risk High risk Low risk
doi:10.1371/journal.pone.0074848.t004
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-stu
d
y
h
etero
g
en
eity
(I
2:
9
6
.6
%
,
p
-va
lu
e,
0
.0
0
1
).
T
h
ere
w
a
s
o
n
e
d
a
ta
set
fro
m
N
ig
eria
w
h
ich
w
a
s
restricted
to
ca
esa
rea
n
sectio
n
s.
T
h
ere
w
a
s
n
o
evid
en
ce
o
f
a
n
a
sso
cia
tio
n
b
etw
een
H
IV
a
n
d
p
o
stp
a
rtu
m
p
reg
n
a
n
cy-in
d
u
ced
h
yp
erten
sio
n
(O
R
:
0
.3
3
,
9
5
%
C
I
0
.0
1
–
8
.2
1
).
Effe
ct
o
f
H
IV
o
n
d
ysto
cia
T
h
ere
w
ere
o
n
ly
six
d
a
ta
sets
w
h
ere
th
e
o
u
tco
m
e
co
u
ld
b
e
b
ro
a
d
ly
ca
teg
o
rised
a
s
d
ysto
cia
(T
a
b
le
1
,
F
ig
u
re
4
).
O
n
e
d
a
ta
set
fro
m
R
w
a
n
d
a
fo
u
n
d
n
o
a
sso
cia
tio
n
b
etw
een
H
IV
a
n
d
d
ysto
cia
(O
R
:
1
.0
4
,
9
5
%
C
I
0
.5
9
–
1
.8
2
),
w
h
ilst
a
stu
d
y
fro
m
T
h
a
ila
n
d
in
d
ica
ted
th
a
t
H
IV
-in
fected
w
o
m
en
h
a
ve
n
ea
rly
eig
h
t
tim
es
th
e
o
d
d
s
o
f
p
ro
lo
n
g
ed
la
b
o
u
r
co
m
p
a
red
w
ith
u
n
in
fected
w
o
m
en
(O
R
:
7
.8
6
,
9
5
%
C
I:
4
.6
4
–
1
3
.3
3
).
T
w
o
d
a
ta
sets
rep
o
rted
o
n
a
b
n
o
rm
a
l
p
resen
ta
tio
n
,
a
n
d
th
ere
w
a
s
n
o
evid
en
ce
fo
r
a
n
a
sso
cia
tio
n
b
etw
een
H
IV
a
n
d
a
b
n
o
rm
a
l
p
resen
ta
tio
n
in
th
e
m
eta
-a
n
a
lysis
(su
m
m
a
ry
O
R
:
1
.1
7
,
9
5
%
C
I:
0
.6
8
–
2
.0
3
,
I
2:
0
%
,
p
=
0
.5
0
).
C
o
n
versely,
b
o
th
d
a
ta
sets
w
h
ich
co
m
p
a
red
th
e
p
reva
len
ce
o
f
u
terin
e
ru
p
tu
re
sh
o
w
ed
a
n
in
crea
sed
risk
in
H
IV
-in
fected
w
o
m
en
,
g
ivin
g
a
su
m
m
a
ry
O
R
o
f
3
.1
4
(9
5
%
C
I:
1
.5
1
–
6
.5
0
,
I
2:0
%
,
p
=
0
.8
9
).
Effe
ct
o
f
H
IV
o
n
in
trau
te
rin
e
in
fe
ctio
n
s
F
ig
u
re
5
sh
o
w
s
th
e
a
sso
cia
tio
n
b
etw
een
H
IV
a
n
d
in
tra
u
terin
e
in
fectio
n
s.
M
eta
-a
n
a
lysis
b
a
sed
o
n
fo
u
r
d
a
ta
sets
in
d
ica
ted
th
a
t
F
ig
u
re
4
.
F
o
re
st
p
lo
t
sh
o
w
in
g
th
e
stre
n
g
th
o
f
a
sso
cia
tio
n
b
e
tw
e
e
n
H
IV
a
n
d
d
y
sto
cia
.
*A
d
ju
ste
d
o
d
d
s
ratio
.
d
o
i:1
0
.1
3
7
1
/jo
u
rn
al.p
o
n
e.0
0
7
4
8
4
8
.g
0
0
4
H
IV
an
d
th
e
R
isk
o
f
D
ire
ct
O
b
ste
tric
C
o
m
p
licatio
n
s
P
LO
S
O
N
E
|
w
w
w
.p
lo
so
n
e
.o
rg
3
0
O
cto
b
e
r
2
0
1
3
|
V
o
lu
m
e
8
|
Issu
e
1
0
|
e
7
4
8
4
8
H
IV
-in
fected
w
o
m
en
h
a
ve
o
ver
th
ree
tim
es
th
e
o
d
d
s
o
f
h
a
vin
g
p
u
erp
era
l
sep
sis
co
m
p
a
red
w
ith
u
n
in
fected
w
o
m
en
(su
m
m
a
ry
O
R
3
.4
3
,
9
5
%
C
I:
2
.0
0
–
5
.8
5
,
I
2:
9
.4
%
,
p
-va
lu
e
=
0
.3
5
).
T
h
ere
w
a
s
a
lso
evid
en
ce
fro
m
eig
h
t
d
a
ta
sets
th
a
t
H
IV
-in
fected
w
o
m
en
h
a
d
o
ver
2
.5
tim
es
th
e
risk
o
f
en
d
o
m
etritis
co
m
p
a
red
w
ith
u
n
in
fected
w
o
m
en
(su
m
m
a
ry
O
R
2
.5
1
,
9
5
%
C
I:
1
.5
0
–
4
.2
1
,
I
2:
1
9
.6
%
,
p
-
va
lu
e
=
0
.2
7
).
T
h
e
resu
lts
o
f
th
e
m
eta
-a
n
a
lyses
fo
r
w
o
m
en
w
h
o
h
a
d
a
ca
esa
rea
n
sectio
n
a
re
p
resen
ted
in
F
ig
u
re
6
.
T
h
e
p
o
o
led
O
R
fro
m
fo
u
r
d
a
ta
sets
in
d
ica
ted
th
a
t
H
IV
-in
fected
w
o
m
en
h
a
d
n
ea
rly
six
tim
es
h
ig
h
er
o
d
d
s
o
f
su
fferin
g
fro
m
p
u
erp
era
l
sep
sis
co
m
p
a
red
w
ith
th
eir
u
n
in
fected
co
u
n
terp
a
rts
(su
m
m
a
ry
O
R
5
.8
1
,
9
5
%
C
I:
2
.4
2
–
1
3
.9
7
,
I
2:
0
%
,
p
-va
lu
e
=
0
.9
3
).
A
m
o
n
g
st
th
e
ten
d
a
ta
sets
w
h
ich
co
n
ta
in
ed
in
fo
rm
a
tio
n
o
n
w
o
u
n
d
in
fectio
n
,
th
e
p
o
o
led
O
R
w
a
s
1
.7
5
(9
5
%
C
I:
1
.2
0
–
2
.5
5
)
a
lth
o
u
g
h
th
ere
w
a
s
w
ea
k
evid
en
ce
fo
r
b
etw
een
-stu
d
y
h
etero
g
en
eity
(I
2:
3
0
.1
%
,
p
=
0
.1
7
).
F
in
a
lly,
th
ere
w
ere
1
2
stu
d
ies
w
h
ich
lo
o
ked
a
t
en
d
o
m
etritis
in
H
IV
-
in
fected
a
n
d
u
n
in
fected
w
o
m
en
;
n
in
e
fo
u
n
d
a
h
ig
h
er
o
ccu
rren
ce
in
H
IV
-in
fected
w
o
m
en
.
T
h
e
m
eta
-a
n
a
lysis
sh
o
w
ed
th
a
t
H
IV
-
in
fected
w
o
m
en
h
a
d
o
ver
d
o
u
b
le
th
e
o
d
d
s
o
f
en
d
o
m
etritis
th
a
n
u
n
in
fected
w
o
m
en
(O
R
:
1
.8
6
,
9
5
%
C
I:
1
.2
8
–
2
.7
1
).
T
h
ere
w
a
s
g
o
o
d
evid
en
ce
fo
r
b
etw
een
-stu
d
y
h
etero
g
en
eity
(I
2:
4
7
.0
%
,
p
=
0
.0
4
).
C
ae
sare
an
se
ctio
n
O
f
th
e
stu
d
ies
w
h
ich
in
clu
d
ed
va
g
in
a
l
a
n
d
ca
esa
rea
n
sectio
n
d
eliveries,
1
3
d
id
n
o
t
p
ro
vid
e
in
fo
rm
a
tio
n
o
n
th
e
p
ro
p
o
rtio
n
o
f
H
IV
-in
fected
a
n
d
u
n
in
fected
w
o
m
en
w
h
o
h
a
d
a
ca
esa
rea
n
(o
n
e
sta
ted
th
a
t
th
ere
w
a
s
n
o
d
ifferen
ce
in
th
e
m
o
d
e
o
f
d
elivery
in
H
IV
-
in
fected
a
n
d
u
n
in
fected
w
o
m
en
,
o
n
e
w
a
s
restricted
to
o
n
ly
va
g
in
a
l
d
eliveries,
th
ree
o
n
ly
fo
llo
w
ed
w
o
m
en
d
u
rin
g
p
reg
n
a
n
cy
a
n
d
eig
h
t
d
id
n
o
t
p
ro
vid
e
a
n
y
in
fo
rm
a
tio
n
o
n
th
e
p
ro
p
o
rtio
n
o
f
in
fected
a
n
d
u
n
in
fected
w
o
m
en
h
a
vin
g
ca
esa
rea
n
s).
F
ig
u
re
7
sh
o
w
s
th
e
rela
tive
o
d
d
s
o
f
h
a
vin
g
a
ca
esa
rea
n
fo
r
H
IV
-in
fected
co
m
p
a
red
w
ith
u
n
in
fected
w
o
m
en
a
cro
ss
th
e
1
9
stu
d
ies
w
h
ich
p
ro
vid
ed
d
a
ta
.
T
h
e
O
R
s
va
ried
fro
m
0
.4
0
to
5
.5
5
a
n
d
th
ere
w
a
s
n
o
evid
en
ce
th
a
t
H
IV
-in
fected
w
o
m
en
w
ere
m
o
re
likely
to
h
a
ve
a
ca
esa
rea
n
co
m
p
a
red
w
ith
u
n
in
fected
w
o
m
en
[p
o
o
led
O
R
:
1
.2
0
,
9
5
%
C
I:
0
.8
1
–
1
.7
8
].
H
o
w
ever,
th
ere
w
a
s
stro
n
g
evid
en
ce
fo
r
b
etw
een
-stu
d
y
h
etero
g
en
eity
(I
2:
8
8
.4
%
,
p
,
0
.0
0
1
).
D
iscu
ssio
n
O
u
r
system
a
tic
review
su
g
g
ests
th
a
t
H
IV
in
crea
ses
th
e
risk
o
f
in
tra
u
terin
e
in
fectio
n
s
d
u
rin
g
p
reg
n
a
n
cy,
d
elivery
o
r
th
e
p
o
stp
a
r-
tu
m
.
S
tu
d
ies
in
clu
d
in
g
va
g
in
a
l
a
n
d
ca
esa
rea
n
d
eliveries
in
d
ica
ted
th
a
t
H
IV
-in
fected
w
o
m
en
h
a
d
o
ver
th
ree
tim
es
th
e
risk
o
f
a
p
u
erp
era
l
sep
sis
co
m
p
a
red
w
ith
u
n
in
fected
w
o
m
en
;
th
is
fig
u
re
in
crea
sed
to
n
ea
rly
six
a
m
o
n
g
st
stu
d
ies
o
n
ly
in
clu
d
in
g
w
o
m
en
w
h
o
F
ig
u
re
5
.
F
o
re
st
p
lo
t
sh
o
w
in
g
th
e
stre
n
g
th
o
f
a
sso
cia
tio
n
b
e
tw
e
e
n
H
IV
a
n
d
in
tra
u
te
rin
e
in
fe
ctio
n
.
d
o
i:1
0
.1
3
7
1
/jo
u
rn
al.p
o
n
e.0
0
7
4
8
4
8
.g
0
0
5
H
IV
an
d
th
e
R
isk
o
f
D
ire
ct
O
b
ste
tric
C
o
m
p
licatio
n
s
P
LO
S
O
N
E
|
w
w
w
.p
lo
so
n
e
.o
rg
3
1
O
cto
b
e
r
2
0
1
3
|
V
o
lu
m
e
8
|
Issu
e
1
0
|
e
7
4
8
4
8
d
elivered
b
y
ca
esa
rea
n
.
T
h
e
evid
en
ce
fo
r
a
n
a
sso
cia
tio
n
b
etw
een
H
IV
a
n
d
o
th
er
d
irect
o
b
stetric
co
m
p
lica
tio
n
s
w
a
s
in
co
n
sisten
t.
W
h
ilst
H
IV
w
a
s
a
sso
cia
ted
w
ith
a
n
in
crea
sed
risk
o
f
a
n
tep
a
rtu
m
h
a
em
o
rrh
a
g
e,
th
ere
w
a
s
n
o
evid
en
ce
o
f
a
n
in
crea
sed
risk
o
f
p
la
cen
ta
p
ra
evia
,
p
la
cen
ta
l
a
b
ru
p
tio
n
,
p
o
stp
a
rtu
m
h
a
em
o
rrh
a
g
e
o
r
reta
in
ed
p
la
cen
ta
.
S
im
ila
rly,
H
IV
d
id
a
p
p
ea
r
to
in
crea
se
th
e
risk
o
f
p
reg
n
a
n
cy-in
d
u
ced
h
yp
erten
sio
n
,
b
u
t
n
o
t
o
f
p
re-ecla
m
p
sia
a
n
d
ecla
m
p
sia
.
F
in
a
lly,
w
e
fo
u
n
d
a
n
a
sso
cia
tio
n
b
etw
een
H
IV
a
n
d
b
o
th
u
terin
e
ru
p
tu
re
a
n
d
p
ro
lo
n
g
ed
la
b
o
u
r,
b
u
t
n
o
t
b
etw
een
H
IV
a
n
d
o
th
er
co
m
p
lica
tio
n
s
o
f
d
ysto
cia
.
T
h
e
h
ig
h
er
risk
o
f
in
tra
u
terin
e
in
fectio
n
s
in
H
IV
-in
fected
w
o
m
en
is
b
io
lo
g
ica
lly
p
la
u
sib
le,
a
s
th
e
im
m
u
n
e
su
p
p
ressio
n
a
sso
cia
ted
w
ith
H
IV
in
crea
ses
su
scep
tib
ility
to
in
fectio
n
[5
7
].
C
a
esa
rea
n
sectio
n
s
m
a
y
in
crea
se
th
e
risk
o
f
p
o
stp
a
rtu
m
in
fectio
n
,
b
u
t
ca
esa
rea
n
sectio
n
s
w
ere
eq
u
a
lly
co
m
m
o
n
in
H
IV
-in
fected
a
n
d
u
n
in
fected
w
o
m
en
,
a
n
d
th
e
ex
cess
risk
o
f
in
tra
u
terin
e
in
fectio
n
s
in
H
IV
-in
fected
w
o
m
en
p
ersisted
a
m
o
n
g
ca
esa
rea
n
o
n
ly
d
eliveries.
W
h
eth
er
th
e
ex
cess
risk
o
f
en
d
o
m
etritis
a
n
d
p
u
erp
era
l
sep
sis
in
th
e
in
tra
-
a
n
d
p
o
stp
a
rtu
m
p
erio
d
is
d
irectly
a
ttrib
u
ta
b
le
to
th
e
p
reg
n
a
n
cy
o
r
in
d
irectly
rela
ted
to
H
IV
o
r
A
ID
S
-a
sso
cia
ted
in
fectio
n
s
is
u
n
certa
in
.
In
tra
u
terin
e
in
fectio
n
s
w
ere
m
o
stly
a
scerta
in
ed
fro
m
h
o
sp
ita
l
reco
rd
s,
d
efin
itio
n
s
w
ere
la
ckin
g
,
it
w
a
s
n
o
t
a
lw
a
ys
clea
r
w
h
eth
er
th
e
in
fectio
n
w
a
s
d
ia
g
n
o
sed
d
u
rin
g
p
reg
n
a
n
cy
o
r
th
e
p
o
stp
a
rtu
m
a
n
d
m
icro
b
io
lo
g
ica
l
ex
a
m
in
a
tio
n
w
a
s
n
o
t
d
o
n
e.
T
h
e
sig
n
s
a
n
d
sym
p
to
m
s
su
g
g
estive
o
f
en
d
o
m
etritis
a
n
d
p
u
erp
era
l
sep
sis
in
in
tra
-
o
r
p
o
stp
a
rtu
m
w
o
m
en
m
a
y
h
a
ve
b
een
a
d
irect
co
n
seq
u
en
ce
o
f
th
e
in
crea
sed
p
reva
len
ce
o
f
sex
u
a
lly
tra
n
sm
itted
in
fectio
n
s
a
sso
cia
ted
w
ith
H
IV
[5
8
,5
9
].
In
th
e
2
0
0
8
–
2
0
1
0
co
n
fid
en
tia
l
en
q
u
iries
in
to
m
a
tern
a
l
d
ea
th
s
in
S
o
u
th
A
frica
,
o
n
ly
6
%
o
f
m
a
tern
a
l
d
ea
th
s
in
H
IV
-in
fected
w
o
m
en
w
ere
a
ttrib
u
ted
to
p
reg
n
a
n
cy-rela
ted
sep
sis,
w
h
ile
6
2
%
o
f
d
ea
th
s
w
ere
a
ttrib
u
ted
to
n
o
n
-p
reg
n
a
n
cy-rela
ted
in
fectio
n
s
[6
0
].
W
ith
o
u
t
clea
r
d
efin
itio
n
s
m
iscla
ssifica
tio
n
o
f
n
o
n
-p
reg
n
a
n
cy-rela
ted
in
fectio
n
s
a
s
p
reg
n
a
n
cy-rela
ted
,
o
r
vice
versa
,
ca
n
n
o
t
b
e
ex
clu
d
ed
.
W
e
d
id
n
o
t
fin
d
a
co
n
sisten
t
a
sso
cia
tio
n
b
etw
een
H
IV
a
n
d
th
e
risk
o
f
eith
er
h
a
em
o
rrh
a
g
e,
d
ysto
cia
o
r
h
yp
erten
sive
d
isea
ses
o
f
p
reg
n
a
n
cy.
H
IV
-rela
ted
th
ro
m
b
o
cyto
p
en
ia
a
ffects
a
ro
u
n
d
1
0
%
o
f
H
IV
-in
fected
in
d
ivid
u
a
ls
a
n
d
3
0
%
o
f
in
d
ivid
u
a
ls
w
ith
A
ID
S
,
[6
1
–
F
ig
u
re
6
.
F
o
re
st
p
lo
t
sh
o
w
in
g
th
e
stre
n
g
th
o
f
a
sso
cia
tio
n
b
e
tw
e
e
n
H
IV
a
n
d
in
tra
u
te
rin
e
in
fe
ctio
n
in
stu
d
ie
s
w
h
ich
o
n
ly
lo
o
k
e
d
a
t
ca
e
sa
re
a
n
d
e
liv
e
rie
s.
*A
d
ju
ste
d
o
d
d
s
ratio
.
d
o
i:1
0
.1
3
7
1
/jo
u
rn
al.p
o
n
e.0
0
7
4
8
4
8
.g
0
0
6
H
IV
an
d
th
e
R
isk
o
f
D
ire
ct
O
b
ste
tric
C
o
m
p
licatio
n
s
P
LO
S
O
N
E
|
w
w
w
.p
lo
so
n
e
.o
rg
3
2
O
cto
b
e
r
2
0
1
3
|
V
o
lu
m
e
8
|
Issu
e
1
0
|
e
7
4
8
4
8
6
3
]
b
u
t
it
ra
rely
lea
d
s
to
severe
b
leed
in
g
[6
1
,6
3
].
T
h
e
a
sso
cia
tio
n
b
etw
een
H
IV
a
n
d
u
terin
e
ru
p
tu
re,
co
n
co
m
ita
n
t
w
ith
n
o
a
sso
ci-
a
tio
n
b
etw
een
H
IV
a
n
d
o
th
er
ca
teg
o
ries
o
f
d
ysto
cia
,
m
a
y
su
g
g
est
th
a
t
d
ela
yed
ca
re
seekin
g
in
H
IV
-in
fected
w
o
m
en
p
la
ys
a
ro
le.
H
o
w
ever,
th
is
fin
d
in
g
w
a
s
b
a
sed
o
n
tw
o
stu
d
ies
o
n
ly,
a
n
d
ca
u
tio
n
is
req
u
ired
in
its
in
terp
reta
tio
n
.
T
h
e
o
b
served
a
sso
cia
tio
n
s
b
etw
een
H
IV
a
n
d
b
ro
a
d
ly
d
efin
ed
ca
teg
o
ries
o
f
co
m
p
lica
tio
n
s
su
ch
a
s
a
n
tep
a
rtu
m
h
a
em
o
rrh
a
g
e
o
r
h
yp
erten
sive
d
isea
ses
–
w
h
erea
s
n
o
a
sso
cia
tio
n
w
a
s
fo
u
n
d
b
etw
een
H
IV
a
n
d
m
o
re
n
a
rro
w
ly
d
efin
ed
clin
ica
l
d
ia
g
n
o
ses
su
ch
a
s
p
la
cen
ta
p
ra
evia
,
p
la
cen
ta
l
a
b
ru
p
tio
n
,
p
re-ecla
m
p
sia
o
r
ecla
m
p
sia
–
su
g
g
ests
th
a
t
m
ea
su
rem
en
t
erro
rs
m
a
y
h
a
ve
o
ccu
rred
.
U
n
fo
rtu
n
a
tely,
few
stu
d
ies
p
ro
vid
ed
in
fo
rm
a
-
tio
n
o
n
th
e
n
u
m
b
er
o
f
w
o
m
en
w
ith
m
o
re
th
a
n
o
n
e
d
ia
g
n
o
sis,
a
n
d
w
e
w
ere
n
o
t
a
b
le
to
p
o
o
l
fin
d
in
g
s
w
ith
in
th
e
b
ro
a
d
o
b
stetric
ca
teg
o
ries.
T
h
e
la
ck
o
f
a
n
a
sso
cia
tio
n
b
etw
een
H
IV
a
n
d
ca
esa
rea
n
sectio
n
is
su
rp
risin
g
.
C
a
esa
rea
n
sectio
n
s
h
a
ve
b
een
reco
m
m
en
d
ed
to
p
reven
t
th
e
m
o
th
er-to
-ch
ild
tra
n
sm
issio
n
(P
M
T
C
T
)
o
f
H
IV
in
m
a
n
y
reg
io
n
s,
[6
4
,6
5
]
a
n
d
th
e
m
o
st
co
m
m
o
n
in
d
ica
tio
n
fo
r
ca
esa
rea
n
sectio
n
in
H
IV
-in
fected
w
o
m
en
in
th
e
stu
d
ies
review
ed
w
a
s
P
M
T
C
T
o
f
H
IV
(d
a
ta
n
o
t
sh
o
w
n
).
It
is
p
o
ssib
le
th
a
t
clin
icia
n
s,
p
a
rticu
la
rly
in
lo
w
in
co
m
e
co
u
n
tries,
w
eig
h
th
e
h
ea
lth
risks
a
sso
cia
ted
w
ith
ca
esa
rea
n
sectio
n
s
a
g
a
in
st
th
o
se
o
f
P
M
T
C
T
,
a
n
d
a
re
p
erh
a
p
s
m
o
re
ca
u
tio
u
s
a
b
o
u
t
p
erfo
rm
in
g
ca
esa
rea
n
sectio
n
s
in
H
IV
-in
fected
w
o
m
en
.
A
lth
o
u
g
h
recen
t
g
u
id
elin
es
reco
m
m
en
d
th
a
t
w
o
m
en
w
ith
very
lo
w
vira
l
lo
a
d
s
w
h
o
a
re
o
n
A
R
T
d
o
n
o
t
n
eed
a
ca
esa
rea
n
fo
r
P
M
T
C
T
o
f
H
IV
[6
6
]
w
e
w
o
u
ld
ex
p
ect
a
h
ig
h
er
ra
te
o
f
ca
esa
rea
n
s
a
m
o
n
g
st
H
IV
-in
fected
w
o
m
en
in
h
ig
h
-in
co
m
e
co
u
n
tries
g
iven
th
e
tim
e
p
erio
d
in
w
h
ich
th
e
stu
d
ies
w
ere
co
n
d
u
cted
.
S
tra
tifyin
g
th
e
m
eta
-a
n
a
lysis
b
y
h
ig
h
a
n
d
lo
w
in
co
m
e
co
u
n
tries
d
id
n
o
t
a
lter
th
e
fin
d
in
g
s
(d
a
ta
n
o
t
sh
o
w
n
).
W
e
d
id
n
o
t
system
a
tica
lly
review
th
e
litera
tu
re
to
a
ssess
th
e
a
sso
cia
tio
n
b
etw
een
H
IV
a
n
d
ca
esa
rea
n
sectio
n
s,
h
o
w
ever,
a
n
d
so
m
e
stu
d
ies
m
a
y
h
a
ve
b
een
m
issed
.
T
h
is
review
w
a
s
co
m
p
reh
en
sive
co
verin
g
a
lo
n
g
tim
e
p
erio
d
w
ith
n
o
restrictio
n
o
n
la
n
g
u
a
g
e,
w
o
rld
reg
io
n
o
r
typ
e
o
f
stu
d
y.
T
h
e
stu
d
ies
fo
u
n
d
w
ere
p
red
o
m
in
a
n
tly
co
n
d
u
cted
in
tertia
ry
h
ea
lth
fa
cilities,
h
o
w
ever,
resu
ltin
g
in
th
e
en
ro
lm
en
t
o
f
a
h
ig
h
er
risk
g
ro
u
p
o
f
p
reg
n
a
n
t
w
o
m
en
.
W
h
ile
th
is
w
ill
lea
d
to
a
n
o
verestim
a
-
tio
n
in
th
e
freq
u
en
cy
o
f
o
b
stetric
co
m
p
lica
tio
n
s,
it
is
u
n
likely
th
is
w
ill
h
a
ve
a
ffected
th
e
rela
tive
o
d
d
s
co
m
p
a
rin
g
H
IV
-in
fected
a
n
d
u
n
in
fected
w
o
m
en
.
T
h
e
m
a
in
lim
ita
tio
n
o
f
th
is
review
is
th
e
p
o
o
r
q
u
a
lity
o
f
in
clu
d
ed
stu
d
ies,
n
o
n
e
o
f
w
h
ich
w
ere
cla
ssified
a
s
a
t
lo
w
risk
o
f
b
ia
s
a
cro
ss
a
ll
th
e
q
u
a
lity
co
m
p
o
n
en
ts.
N
o
ta
b
ly,
o
n
ly
2
5
d
a
ta
sets
co
n
tro
lled
fo
r
key
co
n
fo
u
n
d
ers,
eith
er
th
ro
u
g
h
m
a
tch
in
g
H
IV
-in
fected
a
n
d
u
n
in
fected
w
o
m
en
o
r
th
ro
u
g
h
a
d
ju
stm
en
t
in
th
e
a
n
a
lysis.
F
u
rth
erm
o
re,
very
few
stu
d
ies
p
ro
vid
ed
in
fo
rm
a
tio
n
o
n
h
o
w
th
e
o
b
stetric
co
m
p
lica
tio
n
s
w
ere
d
efin
ed
o
r
a
scerta
in
ed
.
W
h
eth
er
th
e
risks
a
n
d
stig
m
a
a
sso
cia
ted
w
ith
H
IV
m
a
y
resu
lt
in
h
ea
lth
p
ro
fessio
n
a
ls
rep
o
rtin
g
co
m
p
lica
tio
n
s
d
ifferen
tia
lly
in
H
IV
-
in
fected
a
n
d
u
n
in
fected
w
o
m
en
is
n
o
t
kn
o
w
n
,
b
u
t
in
fo
rm
a
tio
n
b
ia
s
certa
in
ly
n
eed
s
co
n
sid
erin
g
.
U
n
fo
rtu
n
a
tely,
d
u
e
to
th
e
lim
ited
n
u
m
b
er
o
f
stu
d
ies
in
clu
d
ed
in
th
is
review
,
it
w
a
s
n
o
t
p
o
ssib
le
to
tea
se
o
u
t
th
e
effect
o
f
A
R
T
b
y
restrictin
g
a
n
a
lyses
to
stu
d
ies
co
n
d
u
cted
w
h
en
A
R
T
w
a
s
a
va
ila
b
le.
F
ig
u
re
7
.
F
o
re
st
p
lo
t
sh
o
w
in
g
th
e
stre
n
g
th
o
f
a
sso
cia
tio
n
b
e
tw
e
e
n
H
IV
a
n
d
ca
e
sa
re
a
n
se
ctio
n
in
stu
d
ie
s
in
clu
d
e
d
in
th
is
sy
ste
m
a
tic
re
v
ie
w
.
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o
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/jo
u
rn
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o
n
e.0
0
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4
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4
8
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0
0
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H
IV
an
d
th
e
R
isk
o
f
D
ire
ct
O
b
ste
tric
C
o
m
p
licatio
n
s
P
LO
S
O
N
E
|
w
w
w
.p
lo
so
n
e
.o
rg
3
3
O
cto
b
e
r
2
0
1
3
|
V
o
lu
m
e
8
|
Issu
e
1
0
|
e
7
4
8
4
8
H
IV
-in
fected
w
o
m
en
a
re
th
o
u
g
h
t
to
b
e
eig
h
t
tim
es
m
o
re
likely
to
d
ie
in
p
reg
n
a
n
cy
o
r
th
e
p
o
stp
a
rtu
m
th
a
n
H
IV
-u
n
in
fected
w
o
m
en
,
[6
7
,6
8
]
a
n
d
th
e
ex
cess
m
o
rta
lity
a
ttrib
u
ta
b
le
to
H
IV
a
m
o
n
g
H
IV
-in
fected
w
o
m
en
is
a
b
o
u
t
9
9
4
p
er
1
0
0
,0
0
0
p
reg
n
a
n
t
w
o
m
en
[6
7
].
W
h
ile
th
e
in
crea
sed
risk
o
f
p
u
erp
era
l
sep
sis
a
n
d
en
d
o
m
etritis
in
H
IV
-in
fected
w
o
m
en
co
n
trib
u
tes
to
th
is,
d
irect
o
b
stetric
ca
u
ses
o
n
ly
ex
p
la
in
a
tin
y
fra
ctio
n
o
f
th
e
ex
cess
m
o
rta
lity.
S
tu
d
ies
o
n
th
e
ca
u
ses
o
f
d
ea
th
in
p
reg
n
a
n
t
o
r
p
o
stp
a
rtu
m
w
o
m
en
b
y
H
IV
sta
tu
s
a
re
sca
rce,
ex
cep
t
fo
r
th
e
S
o
u
th
A
frica
n
co
n
fid
en
tia
l
en
q
u
iries,
th
e
m
o
st
recen
t
o
f
w
h
ich
co
ver
2
,7
5
6
a
n
d
1
,1
4
9
m
a
tern
a
l
d
ea
th
s
in
H
IV
-in
fected
a
n
d
u
n
in
fected
w
o
m
en
resp
ec-
tively
[6
0
].
T
h
e
2
0
0
8
–
2
0
1
0
co
n
fid
en
tia
l
en
q
u
iries
su
g
g
est
th
a
t
m
o
st
d
ea
th
s
in
H
IV
-in
fected
p
reg
n
a
n
t
a
n
d
p
o
stp
a
rtu
m
w
o
m
en
a
re
d
u
e
to
n
o
n
-p
reg
n
a
n
cy-rela
ted
in
fectio
n
s,
in
clu
d
in
g
p
n
eu
m
o
n
ia
,
tu
b
ercu
lo
sis
a
n
d
m
en
in
g
itis
[6
0
].
A
lth
o
u
g
h
a
n
a
em
ia
is
th
o
u
g
h
t
to
b
e
ex
a
cerb
a
ted
b
y
H
IV
,
[7
]
th
e
co
n
fid
en
tia
l
en
q
u
iries
fin
d
a
sim
ila
r
p
ro
p
o
rtio
n
o
f
m
a
tern
a
l
d
ea
th
s
a
ttrib
u
ta
b
le
to
severe
a
n
a
em
ia
in
H
IV
-in
fected
a
n
d
u
n
in
fected
w
o
m
en
(8
%
a
n
d
1
0
%
resp
ectively)
[6
0
].
It
is
essen
tia
l
to
en
su
re
th
a
t
b
o
th
H
IV
-in
fected
a
n
d
u
n
in
fected
p
reg
n
a
n
t
w
o
m
a
n
h
a
ve
rea
d
y
a
ccess
to
h
ig
h
q
u
a
lity
a
n
ten
a
ta
l
a
n
d
d
elivery
serv
ices
to
co
rrectly
d
ia
g
n
o
se
a
n
d
m
a
n
a
g
e
d
irect
o
b
stetric
co
m
p
lica
tio
n
s
w
h
en
th
ey
o
ccu
r.
H
IV
-in
fected
p
reg
n
a
n
t
w
o
m
en
w
ill
a
lso
b
en
efit
fro
m
p
ro
p
h
yla
ctic
a
n
tib
io
tics
d
u
rin
g
la
b
o
u
r
to
red
u
ce
th
eir
risk
o
f
in
tra
u
terin
e
in
fectio
n
s
[6
9
].
H
o
w
ever,
g
iven
th
a
t
m
o
st
o
f
th
e
ex
cess
m
o
rta
lity
a
sso
cia
ted
w
ith
H
IV
in
p
reg
n
a
n
cy
is
d
irectly
rela
ted
to
H
IV
ra
th
er
th
a
n
to
a
h
ig
h
er
risk
o
f
o
b
stetric
co
m
p
lica
tio
n
s,
th
e
g
rea
test
im
p
a
ct
o
n
p
reg
n
a
n
cy-rela
ted
m
o
rta
lity
w
ill
co
m
e
fro
m
en
su
rin
g
th
a
t
H
IV
-in
fected
p
reg
n
a
n
t
w
o
m
en
h
a
ve
a
d
eq
u
a
te
a
ccess
to
A
R
T
[7
0
].
T
h
e
W
o
rld
H
ea
lth
O
rg
a
n
iza
tio
n
reco
m
m
en
d
s
th
e
p
ro
visio
n
o
f
lifelo
n
g
A
R
T
trea
tm
en
t
fo
r
a
ll
H
IV
-
in
fected
p
reg
n
a
n
t
w
o
m
en
w
ith
a
C
D
4
co
u
n
t
b
elo
w
3
5
0
cells/
m
m
3,
b
u
t
m
a
n
y
co
u
n
tries
a
re
still
tra
n
sitio
n
in
g
to
th
ese
g
u
id
elin
es
[7
1
,7
2
].
S
ca
lin
g
u
p
O
p
tio
n
B+
,
w
h
ere
a
ll
p
reg
n
a
n
t
m
o
th
ers
sta
rt
A
R
T
reg
a
rd
less
o
f
th
eir
C
D
4
cell
co
u
n
t
a
n
d
th
en
co
n
tin
u
e
ta
kin
g
it
fo
r
life,
h
a
s
b
een
p
ro
p
o
sed
a
s
a
n
a
d
d
itio
n
a
l
stra
teg
y
to
b
en
efit
m
a
tern
a
l
h
ea
lth
;
h
o
w
ever,
a
n
y
b
en
efit
m
u
st
b
e
ca
refu
lly
m
ea
su
red
a
g
a
in
st
th
e
p
o
ten
tia
l
p
itfa
lls
w
h
ich
in
clu
d
e
th
e
h
ig
h
fin
a
n
cia
l
co
sts
o
f
su
ch
a
p
ro
g
ra
m
m
e
a
n
d
p
o
ssib
le
p
o
o
r
a
d
h
eren
ce
to
A
R
T
a
m
o
n
g
st
w
o
m
en
w
h
o
p
erceive
th
em
selves
to
b
e
h
ea
lth
y
[7
3
].
S
u
p
p
o
rtin
g
In
fo
rm
a
tio
n
F
ig
u
re
S
1
F
u
n
n
e
l
p
lo
t
illu
stra
tin
g
p
o
te
n
tia
l
p
u
b
lic
a
tio
n
b
ia
s
fo
r
d
a
ta
se
ts
w
h
ic
h
lo
o
k
a
t
th
e
a
sso
c
ia
tio
n
b
e
tw
e
e
n
H
IV
a
n
d
p
re
-e
c
la
m
p
sia
.
(E
P
S
)
F
ile
S
1
S
e
a
rc
h
S
tra
te
g
y
.
(D
O
C
X
)
A
ck
n
o
w
le
d
g
m
e
n
ts
T
h
e
a
u
th
o
rs
w
o
u
ld
like
to
th
a
n
k
C
h
risto
p
h
er
G
ro
llm
a
n
fo
r
screen
in
g
a
2
0
%
sa
m
p
le
o
f
a
b
stra
cts
a
n
d
A
lm
a
A
d
ler,
L
en
ka
B
en
o
va
,
Jo
h
n
B
ra
d
ley,
F
ra
n
cesca
C
a
va
lla
ro
,
E
lisa
b
eth
E
ckersb
erg
er,
K
ry
styn
a
M
a
k
o
w
iecka
,
T
o
sh
ie
M
izu
n
u
m
a
,
C
ristin
a
M
o
ya
a
n
d
T
in
g
W
a
n
g
fo
r
th
eir
h
elp
tra
n
sla
tin
g
a
rticles.
A
u
th
o
r
C
o
n
trib
u
tio
n
s
C
o
n
ceived
a
n
d
d
esig
n
ed
th
e
ex
p
erim
en
ts:
C
C
C
R
.
P
erfo
rm
ed
th
e
ex
p
erim
en
ts:
C
C
.
A
n
a
ly
zed
th
e
d
a
ta
:
C
C
.
C
o
n
trib
u
ted
rea
g
en
ts/
m
a
teria
ls/
a
n
a
lysis
to
o
ls:
C
C
.
W
ro
te
th
e
p
a
p
er:
C
C
C
R
.
R
e
fe
re
n
ce
s
1
.
A
b
d
o
o
l-K
a
rim
Q
,
A
b
o
u
Z
a
h
r
C
,
D
eh
n
e
K
,
M
a
n
g
ia
terra
V
,
M
o
o
d
ley
J,
et
a
l.
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0
1
0
)
H
IV
a
n
d
m
a
tern
a
l
m
o
rta
lity:
tu
rn
in
g
th
e
tid
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T
h
e
L
a
n
cet
3
7
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1
9
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.
M
cIn
ty
re
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0
0
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)
M
o
th
ers
in
fected
w
ith
H
IV
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R
ed
u
cin
g
m
a
tern
a
l
d
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a
n
d
d
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b
ility
d
u
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g
p
reg
n
a
n
cy.
B
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M
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B
u
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.
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.
L
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g
ren
S
,
M
a
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,
A
n
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B
,
S
tra
n
d
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,
B
red
b
erg
-R
a
d
en
U
,
et
a
l.
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9
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P
a
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o
f
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IV
v
ira
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n
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n
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reg
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n
cy
in
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.
S
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n
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.
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.
R
ich
K
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,
S
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n
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g
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R
yd
m
a
n
R
J,
L
a
n
d
a
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A
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9
9
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)
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D
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lym
p
h
o
cytes
in
p
erin
a
ta
l
h
u
m
a
n
im
m
u
n
o
d
eficien
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s
(H
IV
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fectio
n
:
ev
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en
ce
fo
r
p
reg
n
a
n
cy-in
d
u
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im
m
u
n
e
d
ep
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n
in
u
n
in
fected
a
n
d
H
IV
-
in
fected
w
o
m
en
.
J
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D
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1
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1
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.
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.
F
ren
ch
R
,
B
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u
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P
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9
9
8
)
T
h
e
effect
o
f
p
reg
n
a
n
cy
o
n
su
rviva
l
in
w
o
m
en
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fected
w
ith
H
IV
a
system
a
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review
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f
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n
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n
a
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a
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O
b
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V
erk
u
y
l
D
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P
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b
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lo
g
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h
p
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o
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IV
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n
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h
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n
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M
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)
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n
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a
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n
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r
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S
a
fe
M
o
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o
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itia
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l
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